The other combines 200mg emtricitabine and 25mg of tenofovir alafenamide in a blue, rectangular, film-coated tablet. Geneva: World Health Organization, 2013. Avoid co-administration of strong CYP3A4 inducers such as rifamycins (ie, rifampin, rifapentine, and rifabutin) or moderate CYP3A4 inducers such as efavirenz, during treatment with SIRTURO ® aptekabezrecepty.com. Caps: avoid metronidazole, disulfiram.